Search Results Search Sort by RelevanceMost Recent Case and Commentary Jun 2004 Unnecessary Tests and Ethics of Quality of Care G. Caleb Alexander, MD Patients' requests for unnecessary medical tests erode health care quality for all. Virtual Mentor. 2004;6(6):261-263. doi: 10.1001/virtualmentor.2004.6.6.ccas3-0406. State of the Art and Science Oct 2004 Surgery for Bowel Obstruction in Ovarian Cancer Jennifer Reenan, MD Palliative surgery can be considered for terminally ill patients with bowel obstruction if the patient is likely to benefit from the surgery. Virtual Mentor. 2004;6(10):449-451. doi: 10.1001/virtualmentor.2004.6.10.cprl1-0410. State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Imatinib is a pharmaceutical therapy recently approved by the FDA to help treat chronic myeloid leukemia. Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411. Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Current page 13
Case and Commentary Jun 2004 Unnecessary Tests and Ethics of Quality of Care G. Caleb Alexander, MD Patients' requests for unnecessary medical tests erode health care quality for all. Virtual Mentor. 2004;6(6):261-263. doi: 10.1001/virtualmentor.2004.6.6.ccas3-0406.
State of the Art and Science Oct 2004 Surgery for Bowel Obstruction in Ovarian Cancer Jennifer Reenan, MD Palliative surgery can be considered for terminally ill patients with bowel obstruction if the patient is likely to benefit from the surgery. Virtual Mentor. 2004;6(10):449-451. doi: 10.1001/virtualmentor.2004.6.10.cprl1-0410.
State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Imatinib is a pharmaceutical therapy recently approved by the FDA to help treat chronic myeloid leukemia. Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411.